Experimental Trial Saves Woman with Stage 4 Colon Cancer
Emma Dimery, a Minnesota woman with stage 4 colon cancer, shares how an experimental trial led by Dr. Emil Lou at the University of Minnesota saved her life. The trial used genetic therapy to treat her cancer, resulting in a remarkable and unprecedented level of response, with Dimery being pronounced cancer-free after just one infusion.
Key Points
- Emma Dimery's remarkable response to the experimental immunotherapy
- Dr. Emil Lou's description of the genetic therapy as the 'next frontier of immunotherapy'
- Importance of genetic testing in determining eligibility for clinical trials
Pros
- Successful treatment of stage 4 colon cancer
- Innovative use of genetic therapy in clinical trial
- Promising results for patients with treatment-resistant cancer
Cons
- Long and grueling treatment process with challenging side effects